The Avatar Acceptability Study: Survivor, Parent and Community Willingness to Use Patient-Derived Xenografts to Personalize Cancer Care

BACKGROUND: Using patient-derived xenografts (PDXs) to assess chemosensitivity to anti-cancer agents in real-time may improve cancer care by enabling individualized clinical decision-making. However, it is unknown whether this new approach will be met with acceptance by patients, family and communit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakefield, C.E., Doolan, E.L., Fardell, J.E., Signorelli, C., Quinn, V.F., Tucker, K.M., Patenaude, A.F., Marshall, G.M., Lock, R.B., Georgiou, G., Cohn, R.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286267/
https://www.ncbi.nlm.nih.gov/pubmed/30385234
http://dx.doi.org/10.1016/j.ebiom.2018.10.060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286267/
https://www.ncbi.nlm.nih.gov/pubmed/30385234
http://dx.doi.org/10.1016/j.ebiom.2018.10.060

Ejemplares similares